Preeti Jha
Overview
Explore the profile of Preeti Jha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
79
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gudge S, Tiwari A, Ratnaparkhe M, Jha P
Comput Biol Chem
. 2025 Mar;
117:108417.
PMID: 40086344
The vast volumes of data are needed to train Deep Learning Models from scratch to identify illnesses in soybean leaves. However, there is still a lack of sufficient high-quality samples....
2.
Lundgren Mortensen A, Berglund H, Jha P, Stenman A, Selvaraju R, Lundqvist H, et al.
Mol Cancer Ther
. 2025 Feb;
PMID: 39976160
Anaplastic thyroid cancer (ATC) is a rare but severe form of thyroid cancer responsible for approximately 50% of thyroid cancer deaths. Consequently, the identification of innovative therapies remains crucial for...
3.
Jha P, Dangi N, Sharma S
Curr Pharm Biotechnol
. 2023 Oct;
25(7):799-806.
PMID: 37877144
Probiotics are beneficial microorganisms shown to improve human health when consumed regularly and in sufficient quantities. Numerous health benefits can be attained by possessing important metabolites with nutritional and medicinal...
4.
Fernandes S, Mohajershojai T, Lundsten S, Sarmento B, Tome J, Nestor M, et al.
J Photochem Photobiol B
. 2023 May;
243:112716.
PMID: 37126865
Photodynamic therapy (PDT) has been used as an alternative or as a complement of conventional approaches for cancer treatment. In PDT, the reactive oxygen species (ROS) produced from the interaction...
5.
Gonzalez P, Debnath S, Chen Y, Hernandez E, Jha P, Dakanali M, et al.
Pharmaceutics
. 2023 Feb;
15(2).
PMID: 36839802
After androgen deprivation therapy, a significant number of prostate cancer cases progress with a therapy-resistant neuroendocrine phenotype (NEPC). This represents a challenge for diagnosis and treatment. Based on our previously...
6.
Koh X, Koh X, Spiegelberg D, Jha P, Nestor M, Hwang L, et al.
Sci Rep
. 2022 Dec;
12(1):22564.
PMID: 36581692
The RON receptor tyrosine kinase is an exceptionally interesting target in oncology and immunology. It is not only overexpressed in a wide variety of tumors but also has been shown...
7.
Mohajershojai T, Jha P, Bostrom A, Frejd F, Yazaki P, Nestor M
Front Oncol
. 2022 Apr;
12:849338.
PMID: 35433442
Carcinoembryonic antigen (CEA) is an antigen that is highly expressed in colorectal cancers and widely used as a tumor marker. I and Y-radiolabeled anti-CEA monoclonal antibodies (mAbs) have previously been...
8.
Lundsten S, Berglund H, Jha P, Krona C, Hariri M, Nelander S, et al.
Biomolecules
. 2021 Nov;
11(11).
PMID: 34827693
p53 is involved in DNA damage response and is an exciting target for radiosensitization in cancer. Targeted radionuclide therapy against somatostatin receptors with Lu-DOTATATE is currently being explored as a...
9.
Jha P, Chaturvedi S, Bhat R, Jain N, Mishra A
J Biomol Struct Dyn
. 2021 Aug;
40(22):11625-11637.
PMID: 34387135
The pharmacologically characterized receptor subtype of the serotonin family, the 5HT1A receptor is implicated in the pathophysiology and treatment of depression and anxiety-related disorders. Being the most extensively targeted receptor...
10.
Jha P, Tiwari A, Bharill N, Ratnaparkhe M, Mounika M, Nagendra N
Comput Biol Chem
. 2021 Mar;
92:107454.
PMID: 33684695
This paper introduces a kernel based fuzzy clustering approach to deal with the non-linear separable problems by applying kernel Radial Basis Functions (RBF) which maps the input data space non-linearly...